Lynx1 Capital Management LP Holdings & Portfolio - 13F Filings Analysis - Stocknear

Lynx1 Capital Management LP

CIK Number: 0001910456

346.17M
Market Value
15
# of Holdings
6 months
Avg. Holding Period
Win Rate
Peformance 3-Years

Filing Date: Aug 14, 2025

Rank Symbol Name Price % Change Shares % Change Shares Market Value Avg. Price Paid % Weight Asset Type
1 MRUS Merus N.V.
94.15
-0.01% 1.57M 0.00% 82.52M 36.34 23.84% Share
2 GHRS GH Research PLC
13.34
-1.69% 6.75M +4.70% 82.25M 10.15 23.76% Share
3 STOK Stoke Therapeut...
24.82
+5.21% 5.4M +2.13% 61.34M 8.5 17.72% Share
4 PTGX Protagonist The...
64.98
+1.53% 733.01K 0.00% 40.51M 48.36 11.70% Share
5 CGEM Cullinan Therap...
5.75
-4.17% 4.4M +36.85% 33.14M 9.3 9.57% Share
6 ALLO Allogene Therap...
1.29
+4.03% 11.06M 0.00% 12.49M 2.4 3.61% Share
7 TCRX TScan Therapeut...
2.18
+4.31% 7.86M +46.66% 11.39M 2.18 3.29% Share
8 CCCC C4 Therapeutics...
2.21
+2.79% 7.1M 0.00% 10.15M 4.78 2.93% Share
9 DTIL Precision BioSc...
5.42
-0.37% 1.04M +35.25% 4.35M 3.91 1.26% Share
10 PASG Passage Bio, In...
8.02
-1.35% 9.26M 0.00% 3.71M 1.04 1.07% Share
11 UPB Upstream Bio, I...
18.59
-0.21% 219.25K 0.00% 2.41M 16.44 0.70% Share
12 IBIO iBio, Inc.
0.83
+1.23% 1.54M +78.43% 1.17M 2.02 0.34% Share
13 NEUP Neuphoria Thera...
14.19
+2.45% 45.81K 0.00% 325.22K 3.43 0.09% Share
14 DSGN Design Therapeu...
6.01
-11.41% 65.95K 0.00% 222.26K 3.86 0.06% Share
15 ASMB Assembly Biosci...
23.70
-3.7% 10.37K +100.00% 187.83K 18.12 0.05% Share